SEP 8, 2026 · PHASE 3 TRIAL
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)
ClinicalTrials.gov
This is a completed Phase 3 RCT registration with no posted results; the primary endpoint (overall survival) and outcomes are not reported in this registry record, making it impossible to assess efficacy or safety.
Reported
Sample size705
PhasePhase 3
Primary outcome measureOverall survival, from date of randomizatio…